RxDoctor Payments DataLook up a doctor →

Deidra Bobincheck, NP

Adult Health · Euclid, OHNPI 1770917346

Payments from drug & device makers

$17,784in general payments, 2019–2025

Across 923 payments — averaging $19.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • AstraZeneca$1K
  • GSK$1K
  • Lilly USA, LLC$1K
  • Pfizer$1K
  • Novo Nordisk$866
  • plus $10K from 54 others

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie91$1,476
AstraZeneca(2 entities)66$1,400
GSK73$1,335
Lilly USA, LLC77$1,319
Pfizer66$1,091
Novo Nordisk57$866
Otsuka America Pharmaceutical, Inc.38$843
Bayer30$822
Amgen(2 entities)32$700
E.r. Squibb & Sons, L.L.C.36$587
Novartis33$502
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)19$455
Merck25$444
Corcept Therapeutics11$423
Phathom Pharmaceuticals, Inc.16$371
Abbott16$335
Exact Sciences14$329
Lundbeck LLC18$322
Boehringer Ingelheim20$319
Johnson & Johnson12$271
Axsome Therapeutics, Inc.11$255
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC13$250
Alkermes, Inc.11$243
Sanofi-aventis U.S. LLC9$229
Dexcom, Inc.11$203
Merz North America, Inc.3$200
Sunovion Pharmaceuticals Inc.14$190
Vivus LLC10$173
Sumitomo Pharma America, Inc.9$155
Teva Pharmaceuticals USA, Inc.8$144
Mylan Specialty L.p.7$135
Xeris Pharmaceuticals, Inc.6$122
Takeda Pharmaceuticals U.S.A., Inc.6$114
Nestle Healthcare Nutrition Inc.7$110
Revance Therapeutics, Inc.1$107
Optinose US, Inc.4$88
Vanda Pharmaceuticals Inc.4$84
Aimmune Therapeutics, Inc.4$68
Amarin Pharma, Inc.3$65
Mannkind Corporation2$55
UCB, Inc.2$50
Astellas Pharma US Inc3$48
Biohaven Pharmaceuticals, Inc.3$47
Abiomed1$41
Scilex Pharmaceuticals Inc.2$40
Neurocrine Biosciences, Inc.2$38
Paratek Pharmaceuticals, Inc.2$38
Eisai Inc.2$32
Viatris Specialty LLC1$31
Nabriva Therapeutics, PLC2$30
Evoke Pharma, Inc.1$25
Ardelyx, Inc.1$22
Radius Health, Inc.1$21
Biohaven Pharmaceutical Holding Company Ltd.1$20
Avanir Pharmaceuticals, Inc.1$20
Biogen1$19
Seqirus USA Inc1$17
Regeneron Healthcare Solutions, Inc.1$17
Ultragenyx Pharmaceutical Inc.1$15
Esperion Therapeutics, Inc.1$13

How this compares

$17,784 in reported general payments places this provider in the 95th percentile of 1,184 adult health providers in Ohio.

See all adult health providers in Ohio →

Medicare billing

Part B allowed, 2024
$76,531
Medicare patients
279
Services billed
1,112

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other adult health in Euclid

See the full list for Ohio →

Where these figures come from

Is this you, or does something look wrong? →